Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2025-12-24 @ 6:47 PM
NCT ID:
NCT00986557
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Planning allogeneic peripheral blood stem cell transplantation (PBSCT) using a conditioning regimen containing alemtuzumab and radiotherapy
* Sibling or matched unrelated donor available
* Patients and donor matched for ≥ one of the following HLA alleles:
* HLA-A\*0101
* HLA\*0201
* HLA-A\*1101
* HLA-A\*2402
* HLA-B\*0702
* HLA-B\*0801
* HLA-B\*3502
* No donors whose stem cells have already been collected and cryopreserved prior to transplant
* Patient and donor must be CMV seropositive
* Stem cell harvests ≥ 4.0 x 10\^6 CD34 cells/kg
PATIENT CHARACTERISTICS:
* See Disease Characteristics
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No prior bone marrow transplantation
* No concurrent participation in another therapeutic transplantation study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00986557
Study Brief:
Protocol Section:
NCT00986557